Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised several concerns for patients with chronic immune-mediated diseases, including inflammatory bowel disease (IBD). As the outbreak appears to be in the descending phase, a...
Main Authors: | Alfredo Papa, Valerio Papa, Loris Riccardo Lopetuso, Antonio Gasbarrini, Antonio Tursi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756284820968747 |
Similar Items
-
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
by: Alfredo Papa, et al.
Published: (2020-07-01) -
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
by: Loris Riccardo Lopetuso, et al.
Published: (2020-06-01) -
Can We Predict the Efficacy of Anti-TNF-α Agents?
by: Loris Riccardo Lopetuso, et al.
Published: (2017-09-01) -
Human herpesvirus 8-associated colonic Kaposi’s sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature
by: Valerio Papa, et al.
Published: (2020-03-01) -
Development and Validation of Predictive Assessment of Complicated Diverticulitis Score
by: Marcello Covino, et al.
Published: (2021-01-01)